av/vincerx-pharma--big.svg

COM:VINCERX

Vincerx Pharma, Inc.

  • Stock

Last Close

0.26

22/11 21:00

Market Cap

19.29M

Beta: -

Volume Today

228.99K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-54
-
-10.72M
19,855,455.56%
-39.31M
266.59%
-65.37M
66.30%
-40.16M
38.57%
depreciation and amortization
340K
-
939K
176.18%
915K
2.56%
deferred income tax
1.57M
-
stock based compensation
1.20
-
4.38M
365,166,566.67%
23.31M
432.02%
12.44M
46.64%
3.56M
71.36%
change in working capital
44K
-
-959K
2,279.55%
5.61M
684.88%
-1.02M
118.19%
-4.19M
310.88%
accounts receivables
328K
-
inventory
accounts payables
35K
-
456K
1,202.86%
1.53M
235.09%
1.05M
31.54%
-1.57M
249.90%
other working capital
9K
-
-1.42M
15,822.22%
4.08M
388.41%
-2.07M
150.62%
-2.95M
42.84%
other non cash items
-78.95K
-
5.02M
6,458.78%
-23.36M
565.30%
-6.59M
71.77%
-2.15M
67.38%
net cash provided by operating activities
-35.00K
-
-2.28M
6,411.65%
-33.40M
1,365.64%
-59.60M
78.44%
-40.45M
32.13%
investments in property plant and equipment
-5.26M
-
acquisitions net
purchases of investments
-42.98M
-
-11.82M
72.50%
sales maturities of investments
2.40M
-
53.32M
2,121.71%
other investing activites
-65.64M
-
net cash used for investing activites
-65.64M
-
-5.26M
91.99%
-40.58M
671.74%
41.50M
202.27%
debt repayment
-300K
-
common stock issued
47.43M
-
280K
99.41%
114K
59.29%
common stock repurchased
dividends paid
other financing activites
64.37M
-
41.02M
36.27%
net cash used provided by financing activities
64.07M
-
88.45M
38.05%
280K
99.68%
114K
59.29%
effect of forex changes on cash
65.64M
-
-21K
100.03%
71K
438.10%
-40K
156.34%
net change in cash
-35.00K
-
61.79M
176,654.62%
49.77M
19.45%
-99.83M
300.58%
1.12M
101.12%
cash at beginning of period
61.79M
-
111.56M
80.55%
11.73M
89.48%
cash at end of period
-35.00K
-
61.79M
176,654.62%
111.56M
80.55%
11.73M
89.48%
12.85M
9.55%
operating cash flow
-35.00K
-
-2.28M
6,411.65%
-33.40M
1,365.64%
-59.60M
78.44%
-40.45M
32.13%
capital expenditure
-5.26M
-
free cash flow
-35.00K
-
-2.28M
6,411.65%
-38.66M
1,596.36%
-59.60M
54.17%
-40.45M
32.13%

All numbers in (except ratios and percentages)